DD5-27039-25348
4 vaccinations
15 coded responses
53 check-ins
15 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 837 / ID
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Numbness in hand of arm injectedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth — Feeling: Fair · Site: Redness, Swelling, ItchingFree text: The swollen, itchy, redness at and below injection site is warm and continues to grow in diameterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Fatigue, Glossodynia, Hypogeusia, Oral pain — Feeling: FairFree text: Fatigue, mouth pain, tongue soreness, partial loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2021-11-05
Survey response — day 0, dose 3MedDRA: Ageusia, Glossodynia, Oral pain — Feeling: FairFree text: Tongue soreness, mouth sensitivity, partial loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Glossodynia — Feeling: Fair · Muscle or body achesFree text: Tongue sorenessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Oral discomfort — Feeling: Fair · Site: Swelling · Muscle or body achesFree text: Mouth discomfortMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Glossodynia, Hypogeusia — Feeling: Fair · Site: Swelling, Itching · Muscle or body aches, Fatigue or tirednessFree text: Tongue soreness, partial loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — days 1–6 daily, dose 3MedDRA: Ageusia, Glossodynia — Feeling: Fair · Site: Itching · Fatigue or tirednessFree text: Tongue soreness, partial loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-10
Survey response — days 1–6 daily, dose 3MedDRA: Glossodynia, Hypogeusia — Feeling: Fair · Fatigue or tirednessFree text: Mild tongue soreness, partial loss of tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Survey response — days 1–6 daily, dose 3MedDRA: Glossodynia, Hypogeusia — Feeling: Fair · Fatigue or tirednessFree text: Tongue soreness (mild), partial loss of taste (mild)MedDRA releases: 2024-11 · check-in free text available
-
2021-11-12
Survey response — day 7, dose 3MedDRA: Glossodynia, Hypogeusia — Feeling: Fair · Fatigue or tirednessFree text: Tongue soreness (very mild), partial loss of taste (mild)MedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2021-11-26
-
2021-12-03
Survey response — day 28, dose 3MedDRA: Ageusia, Oral pain — Feeling: FairFree text: Returned partial loss of taste, returned mouth sensitivity and sorenessMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
-
2021-12-17
Survey response — day 42, dose 3MedDRA: Glossodynia, Hypogeusia, Oral pain — Feeling: FairFree text: Worse partial loss of taste. Mouth sensitivity and tongue soreness continued.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-04
- 2022-05-06
-
2022-09-26
Dose 4 — Pfizer-BioNTech
- 2022-09-26
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-09-29
Survey response — days 1–6 daily, dose 4MedDRA: Injection site warmth — Feeling: Good · Site: Pain, SwellingFree text: Warmth at the injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-10
- 2022-10-17
-
2022-10-24
Survey response — day 28, dose 4MedDRA: Paraesthesia — Feeling: FairFree text: Buzzing sensation in left foot, comes and goes in intensityMedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Numbness in hand of arm injected
Systemic reaction (other): The swollen, itchy, redness at and below injection site is warm and continues to grow in diameter
Release 10 — 6 months, dose 2
Symptoms: Fatigue, mouth pain, tongue soreness, partial loss of taste
Release 10 — day 0, dose 3
Systemic reaction (other): Tongue soreness, mouth sensitivity, partial loss of taste
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tongue soreness
Systemic reaction (other): Mouth discomfort
Systemic reaction (other): Tongue soreness, partial loss of taste
Systemic reaction (other): Tongue soreness, partial loss of taste
Systemic reaction (other): Mild tongue soreness, partial loss of taste
Systemic reaction (other): Tongue soreness (mild), partial loss of taste (mild)
Release 10 — day 7, dose 3
Systemic reaction (other): Tongue soreness (very mild), partial loss of taste (mild)
Release 10 — day 28, dose 3
Symptoms: Returned partial loss of taste, returned mouth sensitivity and soreness
Release 10 — day 42, dose 3
Symptoms: Worse partial loss of taste. Mouth sensitivity and tongue soreness continued.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Warmth at the injection site
Release 12 — day 28, dose 4
Symptoms: Buzzing sensation in left foot, comes and goes in intensity
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Glossodynia | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Oral pain | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SRO | Ageusia | · | · | ✓ |
| SRO | Glossodynia | · | · | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Hypogeusia | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Oral discomfort | · | · | ✓ |
| SRO | Oral pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release